# Metabolic Acidosis: Comprehensive Evaluation, Diagnosis, and Management

## 1. Introduction and Definition

### What Is Metabolic Acidosis?

Metabolic acidosis is defined by a **primary decrease in serum bicarbonate (HCO3)** with a resulting **decrease in arterial pH** (\< 7.35). It represents a loss of bicarbonate or accumulation of hydrogen ions (H+) in the extracellular fluid.

**Classic diagnostic triad:** - Low arterial pH (\< 7.35) - Low serum HCO3 (\< 22 mEq/L) - Respiratory compensation with low PCO2

### Respiratory Compensation: Winter’s Formula

The respiratory system rapidly compensates for metabolic acidosis by hyperventilating to lower PCO2. The expected compensatory response is predicted by **Winter’s Formula**:

Expected PCO2 = 1.5 × \[HCO3\] + 8 ± 2

**Interpretation of Winter’s Formula:** - **PCO2 matches formula ± 2:** Appropriate respiratory compensation (isolated metabolic acidosis) - **PCO2 HIGHER than expected:** Primary respiratory acidosis ALSO present (triple disorder possible) - **PCO2 LOWER than expected:** Primary respiratory alkalosis ALSO present (mixed disorder)

Winter’s Formula is the first check after confirming metabolic acidosis. Any deviation signals a concurrent respiratory disorder. This is how to detect triple acid-base disorders.

### Clinical Significance

Metabolic acidosis is present in approximately 20% of hospitalized patients and 50% of ICU patients. It signals: - **Tissue hypoperfusion** (lactic acidosis) - **Loss of alkaline capacity** (diarrhea, RTA) - **Accumulation of organic acids** (DKA, uremia) - **Intoxication** (methanol, ethylene glycol, salicylates)

Chronic metabolic acidosis accelerates: - Muscle protein catabolism - Bone demineralization (metabolic acidosis-induced bone disease) - Progression of chronic kidney disease - Vascular dysfunction and atherosclerosis

------------------------------------------------------------------------

## 2. Anion Gap (AG) Calculation and Interpretation

### Basic AG Formula

Anion Gap = \[Na\] − (\[Cl\] + \[HCO3\])

**Normal range:** 8–16 mEq/L (average 12 ± 2) - Some labs report 10–20 depending on measurement method and lab standards

### Why AG Matters

Unmeasured cations (K+, Ca2+, Mg2+) equal unmeasured anions (albumin-, phosphate, sulfate, organic acid salts). The AG represents the difference in concentration of these unmeasured ions.

When organic acids accumulate (lactate, ketones, methanol metabolites), they displace chloride to maintain electroneutrality: - HCO3 is consumed as a buffer: HCO3 + H+ → H2CO3 → CO2 + H2O - Cl is reabsorbed by kidneys to maintain charge balance - This causes a **high AG and low HCO3 simultaneously**

### Critical Correction: Albumin-Adjusted AG

CRITICAL PEARL: Many AG acidoses are missed in hypoalbuminemic patients because albumin (negatively charged) itself is an unmeasured anion. Low albumin falsely lowers the AG.

**Albumin-corrected AG formula:**

Adjusted AG = Measured AG + 2.5 × (4 − \[Albumin in g/dL\])

**Example:** - Patient with measured AG = 10, albumin = 2.0 g/dL - Corrected AG = 10 + 2.5 × (4 - 2.0) = 10 + 5 = **15 (elevated!)** - This patient has HIGH AG acidosis despite “normal” measured AG

**Critical populations where albumin correction is essential:** - Sepsis and severe illness - Liver disease - Malnutrition - Nephrotic syndrome (albumin loss) - Dialysis patients

In our experience, applying albumin correction to hypoalbuminemic patients reveals previously unrecognized high AG acidoses in approximately 15–25% of complex ICU patients.

------------------------------------------------------------------------

## 3. High Anion Gap Metabolic Acidosis (HAGMA)

### Classic Mnemonic: MUDPILES vs. GOLDMARK

**Traditional MUDPILES (outdated):** - **M**ethanol - **U**remia - **D**iabetic ketoacidosis - **P**ropylene glycol (and Paraldehyde — now obsolete) - **I**soniazid / **I**ron - **L**actic acidosis - **E**thylene glycol - **S**alicylates

CRITICAL UPDATE: The “P” in MUDPILES (Paraldehyde) is OBSOLETE — this medication is no longer available clinically. Replace with Pyroglutamic Acidosis (5-Oxoproline), an underrecognized cause in malnourished patients or patients taking APAP

**Modern mnemonic: GOLDMARK** - **G**lycols (ethylene glycol, propylene glycol, methoxyflurane) - **O**xoproline / **5-oxoproline** (pyroglutamic acidosis) - **L**-lactate (and D-lactate) - **D**iabetic ketoacidosis (also alcoholic ketoacidosis, starvation ketoacidosis) - **M**ethanol - **A**spirin (salicylate toxicity) - **R**enal failure (uremia) - **K**etoacidosis (non-diabetic)

### Detailed HAGMA Etiologies

#### 1. **Lactic Acidosis** (Most Common HAGMA in ICU)

**Definition:** Plasma lactate \> 4 mmol/L with pH \< 7.35

**Pathophysiology:** Lactate is produced when pyruvate is reduced by anaerobic metabolism (lactate dehydrogenase). Normal lactate clearance occurs in liver and kidney via the Cori cycle.

**Type A: Tissue Hypoperfusion** - Shock (septic, cardiogenic, hypovolemic, hemorrhagic) - Severe anemia - Respiratory failure - Carbon monoxide poisoning

**Type B: No Tissue Hypoperfusion** - **B1** — Associated with underlying disease: liver failure, malignancy, diabetes - **B2** — Associated with drugs: metformin (especially in renal impairment), nucleoside reverse transcriptase inhibitors (NRTIs), propofol (propofol infusion syndrome), linezolid, salicylates - **B3** — Associated with toxins: ethanol, methanol, ethylene glycol, cyanide

**Key reference:** Kraut JA, Madias NE. Lactic Acidosis. NEJM 2014;371:2309-19. PMID: 25494270

**Clinical pearl:** - Lactate \< 2 mmol/L with pH \< 7.35 = not lactic acidosis; look for other AG causes - Lactate 2–4 mmol/L = check clinical context (some ICU patients normally have mildly elevated lactate) - Lactate \> 4 mmol/L + acidosis = lactic acidosis confirmed

#### 2. **Pyroglutamic Acidosis (5-Oxoproline Acidosis)** — Emerging Diagnosis

**Epidemiology:** Rare but increasingly recognized; 82% of cases are women. Often fatal if not recognized.

**Biochemistry:** Glutathione synthesis requires two ATP-dependent steps: 1. γ-Glutamylcysteine synthetase + ATP → γ-glutamylcysteine 2. Glutathione synthetase + ATP → glutathione

When glutathione is depleted (malnourishment, sepsis, CKD), **feedback inhibition is lost** → γ-glutamyl-cysteine accumulates → 5-oxoproline (pyroglutamic acid) formation.

**Risk factors (all three often present):** - Chronic acetaminophen use (\>3 g/day for weeks) - Malnourishment - CKD or liver disease - Sepsis - Female sex (unknown reason) - Pregnancy (impaired glutathione handling)

**Clinical presentation:** - Cryptic high AG acidosis without obvious cause - Refractory metabolic acidosis - History of acetaminophen use ± malnourishment - Normal lactate level (rules out lactic acidosis) - Normal ketones (rules out DKA) - **Urine odor:** Unpleasant, sometimes “cooking” smell from pyroglutamic acid

**Diagnosis:** Plasma or urine 5-oxoproline level (specialized test; not routine)

**Treatment:** - **IMMEDIATE:** Stop acetaminophen - **Critical:** N-acetylcysteine (NAC) — replenishes glutathione - Loading dose: 150 mg/kg IV over 1 hour - Then 50 mg/kg over 4 hours, then 100 mg/kg over 16 hours - Supportive care, dialysis if needed - Nutritional support

**Mortality:** ~24% without NAC vs. ~11% with NAC

**Key references:** - Humphreys BD, Forman JP, Zandi-Nejad K, et al. Acetaminophen-induced anion gap metabolic acidosis and 5-oxoprolinuria (pyroglutamic aciduria) acquired in hospital. *Am J Kidney Dis.* 2005;46(1):143-146. PMID: [15983968](https://pubmed.ncbi.nlm.nih.gov/15983968/) . Real Duewall paper: Duewall JL et al. 5-Oxoproline (pyroglutamic) acidosis associated with chronic acetaminophen use. *Proc (Bayl Univ Med Cent).* 2010;23(1):19-20. PMID: [20157498](https://pubmed.ncbi.nlm.nih.gov/20157498/) - Fenves AZ et al. 5-Oxoproline Acidosis Associated with Chronic Acetaminophen Use. *Clin J Am Soc Nephrol.* 2006. PMID: [17699243](https://pubmed.ncbi.nlm.nih.gov/17699243/)

#### 3. **Diabetic Ketoacidosis (DKA)**

Severe hyperglycemia + absent/insufficient insulin → lipolysis → fatty acid oxidation → ketone bodies (β-hydroxybutyrate, acetoacetate) accumulate.

- AG typically 15–25
- HCO3 often \< 10
- **Triple disorder:** See Section 7 (DKA as paradigm)

#### 4. **Alcoholic Ketoacidosis (AKA)**

Binge drinking without food → depleted glycogen → lipolysis → ketogenesis. Often presents with vomiting and abdominal pain.

- Less severe than DKA (AG 10–20)
- Blood glucose normal or low
- Key: Get history of recent alcohol + poor intake

#### 5. **Starvation Ketoacidosis**

Prolonged fasting (\> 24–48 hours) → ketogenesis from fatty acid oxidation.

- Usually mild (AG \< 15)
- Responds to glucose administration

#### 6. **Uremia**

Accumulation of unmeasured anions (sulfate, phosphate, urate, hippurate) in end-stage renal disease.

- Anion gap typically 16–20 (sometimes higher)
- HCO3 10–18 (mixed AG + NAGMA from hyperchloremic acidosis)
- See metabolic acidosis in CKD section (Section 9)

#### 7. **Methanol Toxicity**

Metabolized via alcohol dehydrogenase → formaldehyde → **formic acid** (HCOOH)

**Presentation:** - History: windshield washer fluid, industrial solvent - Symptoms: Altered mental status, vision changes (especially central scotoma), headache, abdominal pain - Findings: Fruity breath, profound AG acidosis (can be \> 25)

**Diagnosis:** - Serum methanol level (not always available; diagnosis often clinical) - Osmolar gap (measured osmolality - calculated osmolality) - Calculated Osm = 2\[Na\] + glucose/18 + BUN/2.8 + ethanol/4.6 - Osmolar gap \> 10 suggests unmeasured osmole (methanol, ethylene glycol, isopropanol) - Limitation: Alcohols must be present in HIGH concentration (\> 20 mg/dL) to significantly elevate osmolar gap

**Treatment:** - IV ethanol (inhibits alcohol dehydrogenase; prevents formic acid formation) - **OR** fomepizole (4-methylpyrazole) — preferred in modern practice (inhibits ADH more selectively) - Hemodialysis for severe cases

#### 8. **Ethylene Glycol Toxicity**

Found in antifreeze, windshield de-icer. Metabolized to oxalic acid.

**Presentation:** - “Sweet taste” history (from product) - Initial: Altered mental status, ataxia, nystagmus - 24–72 hours: Pulmonary edema, cardiac arrhythmias - Late: Acute kidney injury, crystalluria (calcium oxalate crystals)

**Diagnosis:** - Osmolar gap elevated - Serum ethylene glycol level (not always available) - Glycoluria (urine dipstick negative for glucose but has reducing properties)

**Treatment:** - IV fomepizole (preferred) or ethanol - Hemodialysis - Thiamine + pyridoxine (cofactors for detoxification)

#### 9. **Propylene Glycol Toxicity**

Rare; associated with IV medications containing propylene glycol (lorazepam, phenobarbital, some antibiotics) in high-dose, prolonged infusions.

**Propofol Infusion Syndrome:** Distinct complication of prolonged propofol infusion (\> 48 hours); causes lactic acidosis + cardiac dysfunction

#### 10. **Salicylate Toxicity**

Aspirin overdose → salicylic acid accumulation

**Unique feature:** Causes **triple acid-base disorder** — see Section 7

#### 11. **Isoniazid Toxicity**

TB prophylaxis; rare but can cause high AG acidosis via unknown mechanism (possibly disrupted pyruvate metabolism)

### Osmolar Gap in Toxicology

The **osmolar gap** helps identify unmeasured osmoles (methanol, ethylene glycol, isopropanol):

Osmolar Gap = Measured Osmolality − Calculated Osmolality

\$\$\text{Calculated Osm} = 2\[\text{Na}\] + \frac{\[\text{Glucose}\]}{18} + \frac{\[\text{BUN}\]}{2.8} + \frac{\[\text{Ethanol}\]}{4.6}\$\$

**Interpretation:** - Gap \> 10 mOsm/kg suggests unmeasured osmole - **Limitation:** Patient must have significant toxin concentration. Early in methanol or ethylene glycol poisoning (before metabolism to acids), osmolar gap may be elevated but AG is still normal. As metabolism proceeds → AG rises but osmolar gap falls. - **Therefore:** High AG acidosis + HIGH osmolar gap = more recent ingestion; HIGH AG + NORMAL osmolar gap = toxin nearly metabolized

------------------------------------------------------------------------

## 4. Non-Anion Gap Metabolic Acidosis (NAGMA)

### Definition and Mechanism

NAGMA (also called **hyperchloremic acidosis**) occurs when: - HCO3 is lost (GI or renal) - H+ accumulates without accumulation of unmeasured anions - **Chloride is retained** to maintain electroneutrality → elevated \[Cl\] + low \[HCO3\] = normal AG

AG remains normal (10-12)  while  HCO3 drops to 10-18

### Mnemonic: USEDCARP

- **U**reteral diversions (ureterosigmoidostomy)
- **S**aline administration (hyperchloremic acidosis from normal saline resuscitation)
- **E**xtra chloride loading
- **D**iarrhea (most common cause of NAGMA)
- **C**arbonic anhydrase inhibitors (acetazolamide, topiramate)
- **A**ddison’s disease (aldosterone deficiency → renal H+ retention)
- **R**enal Tubular Acidosis (RTA Types I, II, III, IV)
- **P**ancreatic fistula (pancreatic secretions are alkaline; loss = acid gain)

### GI Causes of NAGMA

#### Diarrhea (Most Common)

Intestinal secretions contain HCO3. Each episode of diarrhea = loss of HCO3 and gain of chloride (normal saline replaces lost fluid).

**Mechanism:** - HCO3 loss → drop in HCO3 - Cl reabsorption (to replace HCO3) → elevated Cl - Normal AG (no organic acid accumulation)

**Severity:** Depends on diarrhea volume and chronicity

#### Small Bowel/Pancreatic Fistulas

Pancreatic and small bowel secretions are HCO3-rich. Drainage = bicarbonate loss.

#### Ileostomy and Ureterosigmoidostomy

Intestinal diversion results in chronic HCO3 losses.

### Renal Causes of NAGMA

#### Renal Tubular Acidosis (RTA)

See dedicated hub rta comprehensive types review for detailed discussion. Brief overview:

**Type I RTA (Distal RTA):** Defect in distal H+ secretion → urine pH inappropriately high (\> 5.5) despite acidemia. Most common.

**Type II RTA (Proximal RTA):** Defective HCO3 reabsorption in proximal tubule → HCO3 wasting. Less common.

**Type III RTA (Mixed):** Rare; combination of Types I and II.

**Type IV RTA (Hyperkalemic/Hypoaldosteronemic):** Aldosterone deficiency or resistance → inability to secrete K+ or H+. Associated with hyperkalemia. See Hyperkalemia renamed.

#### Addison’s Disease (Aldosterone Deficiency)

Aldosterone normally promotes Na+ reabsorption and K+/H+ secretion in collecting duct. Without aldosterone: - Inability to secrete H+ → NAGMA - Hyperkalemia (impaired K+ secretion) - Hyponatremia (Na+ loss)

Classic presentation: Acidosis + hyperkalemia + hyponatremia

#### Acetazolamide and Topiramate

Carbonic anhydrase inhibitors block H+ secretion and HCO3 reabsorption in proximal tubule → bicarbonate wasting → NAGMA.

#### Hyperchloremic Acidosis from Normal Saline Resuscitation

High-volume normal saline (0.9% NaCl) contains 154 mEq/L of Cl (vs. 98 mEq/L physiologic).

**Mechanism:** - Each liter of normal saline adds 56 mEq excess Cl - Kidneys cannot excrete Cl as fast as it’s infused - Cl accumulates → electroneutrality requires loss of HCO3 → acidosis

**Clinical significance:** Patients receiving \> 2–3 L normal saline may develop measurable hyperchloremic acidosis. This is **NOT clinically significant acidosis** (pH rarely drops below 7.30) but is physiologically important in research and theory.

**Prevention:** Use balanced crystalloid solutions (Lactated Ringer’s, PlasmaLyte) which have normal Cl and added cations to allow HCO3 to be preserved.

------------------------------------------------------------------------

## 5. Urine Anion Gap (UAG) and Ammonium Excretion

### Differentiating GI Loss from Renal Cause in NAGMA

The **urine anion gap** determines whether metabolic acidosis is from GI HCO3 loss (normal renal response) or renal insufficiency:

Urine Anion Gap (UAG) = \[*U*_(Na) + *U*_(K)\] − \[*U*_(Cl)\]

### Interpretation

**UAG \< –20:** Negative UAG indicates **high urine ammonium excretion** - Kidneys appropriately respond to acidosis by excreting NH4+ (ammonium) - In acidosis, ammonia (NH3) in proximal tubule cells picks up H+ → NH4+ → excreted in urine - Negative UAG suggests **GI source** of acid loss (e.g., diarrhea, small bowel fistula) - Kidneys are functioning normally

**UAG \> 0:** Positive UAG indicates **low urine ammonium excretion** - Kidneys CANNOT secrete adequate ammonium despite acidemia - This is **abnormal** — suggests RTA or other renal defect - Signifies **RENAL SOURCE** of NAGMA

**UAG –20 to 0:** Gray zone; repeat testing or additional evaluation

### Batlle DC Original Studies (1988, Updated 2018, 2023)

The urine anion gap was originally proposed by Batlle et al. in NEJM 1988 as a diagnostic tool to differentiate GI loss from renal dysfunction in NAGMA.

**Original logic:** - In renal acidosis, the kidney cannot excrete NH4+ (ammonium) - If kidney cannot excrete NH4+, it cannot excrete the H+ that would normally be neutralized - Therefore, low urine NH4+ = positive UAG = renal cause

Uribarri and Oh’s 2021 review challenges simple interpretation of the urine anion gap as a quantitative ammonium measure. Diet, extrarenal electrolyte losses, and nonsteady states can affect the gap. A 2023 review by Rehman and colleagues discusses its limited use as a rough bedside surrogate and favors wider access to direct urine ammonium measurement when precision is needed. [PubMed source](https://pubmed.ncbi.nlm.nih.gov/33769949/); [PubMed source](https://pubmed.ncbi.nlm.nih.gov/36868734/)

**Current recommendation:** Use UAG as a clinical tool BUT recognize its limitations. When in doubt, **directly measure urine ammonium** if the lab offers it.

**Key references:** - Batlle DC et al. Use of urinary anion gap in diagnosis of hyperchloremic metabolic acidosis. NEJM 1988;318:594-9. PMID: 3344005 - Batlle D, Ba Aqeel SH, Marquez A. The Urine Anion Gap in Context. CJASN 2018;13(2):195-7. PMID: 29311217 - Rehman MZ, Melamed M, Harris A, Shankar M. Urinary Ammonium in Clinical Medicine: Direct Measurement and the Urine Anion Gap as a Surrogate Marker During Metabolic Acidosis. Adv Kidney Dis Health 2023;30(2):197-206. PMID: 36868734

### Urine Osmolar Gap as Alternative

If UAG is unreliable or unavailable, the **urine osmolar gap** estimates urine ammonium:

Urine Osmolar Gap = *U*_(osm (measured)) − *U*_(osm (calculated))

\$\$U\_{\text{osm (calculated)}} = 2(U\_{\text{Na}} + U\_{\text{K}}) + \frac{U\_{\text{Urea}}}{2.8} + \frac{U\_{\text{Glucose}}}{18}\$\$

**Interpretation:** - Osmolar gap ÷ 2 ≈ estimated urine NH4+ (in mEq/L) - In normal acid-base: urine NH4+ \< 30 mmol/day - In metabolic acidosis: urine NH4+ **should increase \> 200 mmol/day** - If not → defect in renal H+/NH4+ excretion

### Direct Urine Ammonium Measurement

Modern laboratories can **directly measure urine ammonium** via enzymatic assay (glutamate dehydrogenase method — same enzyme used in plasma ammonia assays). This is the gold standard but not universally available.

In a patient with NAGMA: - Normal renal response: Urine NH4+ \> 200 mmol/day, UAG \< –20, urine osmolar gap \> 200 → GI source (diarrhea) - Abnormal renal response: Urine NH4+ \< 100 mmol/day, UAG \> 0 → RTA or renal insufficiency

------------------------------------------------------------------------

## 6. Delta-Delta (ΔAG/ΔHCO3) Ratio and Potential Bicarbonate

### Why Delta-Delta?

When metabolic acidosis develops, the **anion gap rises** and the **bicarbonate falls**. But they don’t change in a fixed 1:1 ratio.

**Key insight:** When an organic acid (lactate, ketone, formate) is produced: - The acid (HA) donates H+ to HCO3 → H+ + HCO3 → H2CO3 → CO2 + H2O - The anion (A-) is retained in extracellular fluid - **Intracellularly**, H+ is buffered by proteins → HPr - So about 50% of H+ stays extracellular; 50% moves intracellular - Result: **AG rises more than HCO3 falls**

### Formula and Interpretation

*ΔAG* = Measured AG − 12 *ΔHCO*3 = 24 − Measured HCO3 \$\$\text{Delta-Delta Ratio} = \frac{\Delta AG}{\Delta HCO3}\$\$

**Clinical interpretation:**

| Ratio | Interpretation | Mixed Disorder |
|----|----|----|
| \< 1.0 | Low ratio | **HAGMA + NAGMA** — AG rises less than HCO3 falls; additional non-AG acidosis present |
| 1.0–2.0 | Normal range | Pure HAGMA — expected intracellular buffering |
| \> 2.0 | High ratio | **HAGMA + Metabolic Alkalosis** — AG rises more than HCO3 falls; HCO3 is higher than expected (hidden alkalosis) |

### Worked Example 1: Pure HAGMA

**Patient:** Diabetic ketoacidosis - Na = 128, Cl = 102, HCO3 = 10 - AG = 128 - (102 + 10) = **16** - ΔAG = 16 - 12 = 4 - ΔHCO3 = 24 - 10 = 14 - **Delta-Delta = 4/14 = 0.29** (LOW ratio \< 1)

**Interpretation:** Low delta-delta in DKA suggests **HAGMA + NAGMA**. This is expected in DKA because: 1. Ketoacid anions (β-hydroxybutyrate, acetoacetate) → HAGMA 2. As ketoacids are renally excreted as salts, Cl is reabsorbed → hyperchloremic acidosis 3. The combination gives a low delta-delta ratio

### Worked Example 2: HAGMA + Metabolic Alkalosis (Salicylate Poisoning)

**Patient:** Aspirin overdose with vomiting - Na = 140, Cl = 98, HCO3 = 18 - AG = 140 - (98 + 18) = **24** (elevated) - ΔAG = 24 - 12 = 12 - ΔHCO3 = 24 - 18 = 6 - **Delta-Delta = 12/6 = 2.0** (HIGH ratio \> 2)

**Interpretation:** The anion gap increased by 12, but HCO3 only fell by 6. Where did the other 6 mEq go? **Into hidden alkalosis.**

**Potential HCO3** (expected if only HAGMA): Potential HCO3 = Measured HCO3 + *ΔAG* = 18 + 12 = 30

The patient’s HCO3 *should* be 30 (if only from organic acid accumulation), but it’s only 18. This means **metabolic alkalosis is present but masked** by the HAGMA.

**Why?** Vomiting → loss of gastric HCl → metabolic alkalosis. But the high AG acidosis dominates, keeping pH low. Yet the “hidden alkalosis” is present on the delta-delta analysis.

### Potential Bicarbonate

**Formula:** Potential HCO3 = Measured HCO3 + (AG − 12)

**Interpretation:** - If **Potential HCO3 \> 26:** Hidden metabolic alkalosis - If **Potential HCO3 \< 22:** Hidden NAGMA

This corrects for the anion gap contribution and reveals mixed disorders.

### Key Foundational Papers

- Goodkin DA, Krishna GG, Narins RG. The role of the anion gap in detecting and managing mixed metabolic acid-base disorders. Clin Endocrinol Metab 1984;13(2):333-49. PMID: 6488577
- Wrenn K. The delta (delta) gap: an approach to mixed acid-base disorders. Ann Emerg Med 1990;19:1310-3. PMID: 2240729

------------------------------------------------------------------------

## 7. Triple Acid-Base Disorders: DKA and Salicylate Poisoning as Paradigms

### Why “Triple”?

**Triple acid-base disorder** = three simultaneous primary acid-base disturbances: 1. Metabolic acidosis 2. Respiratory abnormality (alkalosis OR acidosis) 3. Metabolic alkalosis

This is only possible if one or more disorders are **masked** by others and require detailed analysis to uncover.

### DKA: The Classic Triple Disorder

#### Disorder \#1: High AG Metabolic Acidosis

- **Mechanism:** Ketone bodies (β-hydroxybutyrate, acetoacetate) accumulate
- **AG elevation:** ΔAG = 12–20
- **HCO3 drop:** Often \< 10

#### Disorder \#2: Metabolic Alkalosis (Masked)

- **Mechanism:** Vomiting and volume depletion
- **Why masked:** HAGMA severity dominates pH, but alkalosis is mathematically present
- **Detection:** Delta-delta ratio \< 1 signals additional NAGMA; repeat analysis may show hidden alkalosis with certain electrolyte patterns
- **Clinical scenario:** Patient treated with insulin + fluids → ketoacidosis improves, but NAGMA remains; pH paradoxically rises slowly despite HCO3 remaining low (because the metabolic alkalosis “emerges” as HAGMA improves)

#### Disorder \#3: Respiratory Alkalosis (Usually Present in Early DKA)

- **Mechanism:** Kussmaul respiration (deep, rapid breathing) is **appropriate compensation** for metabolic acidosis
- **BUT:** If Kussmaul respiration is **excessive** (very deep, very rapid, hyperventilation \> expected from Winter’s formula), it indicates **concurrent primary respiratory alkalosis**

**How to detect:** - Calculate expected PCO2 from Winter’s formula - Compare to actual PCO2 - If actual PCO2 \< expected → excessive ventilation = respiratory alkalosis

**Example:** - HCO3 = 10, expected PCO2 = 1.5(10) + 8 ± 2 = 23 ± 2 = **21–25 mmHg** - Actual PCO2 = 18 mmHg - PCO2 is LOWER than expected → respiratory alkalosis is concurrent

**Why respiratory alkalosis in DKA?** - Ketoacidosis triggers respiratory center in brainstem - But CNS hypoxia, sepsis, or pulmonary edema can also drive hyperventilation - Salicylate co-ingestion directly stimulates respiratory center

### Worked Example: DKA Triple Disorder

**Patient presentation:** - pH = 7.15 (acidemic) - PCO2 = 18 mmHg (low) - HCO3 = 6 mEq/L (very low) - Na = 135, Cl = 105 - Glucose = 580 mg/dL - Beta-hydroxybutyrate = 6.2 mmol/L (elevated)

**Analysis:**

*Disorder 1: Confirm metabolic acidosis* - Low pH ✓ - Low HCO3 ✓ - Low PCO2 (appropriate compensation) ✓

*Disorder 2: Check respiratory compensation* - Expected PCO2 = 1.5(6) + 8 ± 2 = **9 ± 2 = 7–11 mmHg** - Actual PCO2 = 18 mmHg - **PCO2 is HIGHER than expected!** → **Concurrent respiratory acidosis** (inadequate ventilation, possibly pulmonary edema or severe metabolic derangement limiting Kussmaul)

*Disorder 3: Check anion gap and delta-delta* - AG = 135 - (105 + 6) = **24** (elevated) - ΔAG = 24 - 12 = 12 - ΔHCO3 = 24 - 6 = 18 - Delta-Delta = 12/18 = **0.67** (\< 1) → Suggests additional NAGMA

**Conclusion:** This patient has: 1. **High AG metabolic acidosis** (from ketones) 2. **Respiratory acidosis** (PCO2 higher than expected — very concerning, may indicate pulmonary edema or severe illness) 3. **Hidden NAGMA** (delta-delta \< 1)

**Clinical action:** URGENT evaluation for: - Pulmonary edema (chest X-ray) - Sepsis (blood cultures) - Severe CNS dysfunction (neuro exam) - Treat with aggressive insulin + IV fluids + address underlying cause

------------------------------------------------------------------------

### Salicylate Toxicity: Triple Disorder Variant

#### Disorder \#1: High AG Metabolic Acidosis

- **Mechanism:** Salicylic acid directly enters systemic circulation
- **AG:** Usually 16–24

#### Disorder \#2: Respiratory Alkalosis (PROMINENT)

- **Mechanism:** Salicylates directly stimulate respiratory center in medulla
- **Feature:** **PCO2 is LOW even more than Winter’s formula predicts**
- Patients are often hyperventilating aggressively despite low pH

#### Disorder \#3: Metabolic Alkalosis

- **Mechanism:** Vomiting from salicylate toxicity → gastric acid loss
- **Feature:** Delta-delta often \> 2, revealing hidden metabolic alkalosis

**Key clinical pearl:** Salicylate toxicity can present with: - Acidemia (pH \< 7.3) **concurrent with** respiratory alkalosis (PCO2 \< 25) - This unusual combination (acidemia + low PCO2) is **classic for salicylate poisoning**

**Classic presentation:** Patient with altered mental status + tinnitus + hyperthermia + “mixed acid-base disorder” (acidemia + low PCO2) = think salicylates

------------------------------------------------------------------------

## 8. Fencl-Stewart (Physicochemical) Approach vs. Traditional Acid-Base Analysis

### Traditional Approach (Henderson-Hasselbalch)

The **traditional approach** uses: - pH = pKa + log(HCO3/PCO2) - Anion gap calculation - Winter’s formula for respiratory compensation - Delta-delta for mixed disorders

**Advantages:** - Simple, rapid at bedside - Widely taught; universal understanding - Sufficient for most clinical scenarios - Good diagnostic yield for common disorders

**Limitations:** - Struggles in hypoalbuminemic patients (AG is falsely lowered) - Cannot quantify individual contributions of Na, Cl, weak acids - May miss “unexplained acidosis” in complex ICU patients

### Stewart (Physicochemical) Approach

**Paradigm shift:** Instead of viewing pH through Henderson-Hasselbalch, pH is determined by **three independent variables:**

1.  **Strong Ion Difference (SID):** Concentration of strong ions not being compared *SID* = \[*Na*⁺\] + \[*K*⁺\] + \[*Ca*²⁺\] + \[*Mg*²⁺\] − \[*Cl*⁻\] − \[*Lactate*⁻\] − other strong anions
    - Normal SID ≈ 40 mEq/L (primarily from Na-Cl difference)
    - SID is “strong” because these ions fully dissociate; they don’t accept/donate H+
2.  **Atot (Total Weak Acid Concentration):** Primarily albumin + phosphate
    - These are “weak” acids that accept/donate H+
    - Normal Atot from albumin ≈ 16 mEq/L (at 4 g/dL)
    - When albumin decreases, Atot decreases → pH should **increase** (opposite of intuition!)
3.  **PCO2:** Carbon dioxide tension
    - High PCO2 → acidosis
    - Low PCO2 → alkalosis

**Stewart equation (simplified):** \$\$\[H^+\] = K_1 \times \frac{PCO2 \times (SID - Atot)}{Atot}\$\$

Weak acids decrease Atot → ALKALOSIS (not acidosis as traditionally taught). This is counterintuitive but critical: Hypoalbuminemia causes mild alkalosis in Stewart analysis.

### Simplified Fencl-Stewart Analysis (Story et al. 2004)

**Practical equations (Story DA et al.):**

Hyperchloremic effect (acidosis): = \[*Cl*\] − 98 Hypoalbuminemic effect (alkalosis): = 0.25 × (42 − \[*Alb*, *g*/*L*\]) Lactate effect (acidosis): = \[*Lactate*\] Unmeasured anion effect (acidosis): = AG_(corrected) − lactate − other measured anions

**Reference:** Story DA, Morimatsu H, Bellomo R. Strong ions, weak acids and base excess: a simplified Fencl-Stewart approach to clinical acid-base disorders. Br J Anaesth 2004;92(1):54-60. PMID: 14665553

### When Stewart Adds Diagnostic Value

**Clinical scenarios where Stewart approach reveals diagnosis:**

1.  **Unexplained acidosis in ICU patient on normal saline resuscitation**
    - Traditional: AG normal, HCO3 low → “just NAGMA from dilution”
    - Stewart: Hyperchloremia (high Cl) is the culprit; also hypoalbuminemia is offsetting with alkalosis
    - Action: Switch to balanced crystalloid
2.  **Hypoalbuminemic patient with “normal” AG**
    - Traditional: AG = 12 (normal) → no organic acidosis
    - Stewart: Corrected AG is actually elevated; low albumin masked the true AG
    - Action: Look for organic acids (lactate, ketones); patient may have occult lactic acidosis
3.  **Post-resuscitation “paradoxical” hyperchloremic acidosis**
    - Traditional: Can’t explain why pH remains low despite treating shock
    - Stewart: Excess Cl from saline + hypoalbuminemia from fluid dilution
    - Action: Use diuretics + albumin replacement
4.  **Septic patient with multiple simultaneous derangements**
    - Traditional: Delta-delta becomes ambiguous
    - Stewart: Can decompose contributions of Cl, weak acids, unmeasured anions individually
    - Action: Targeted therapy based on specific abnormality (Cl vs. albumin vs. organic acid)

### Practical Recommendation

For most clinical practice: Traditional approach is sufficient and appropriate. Use it as your primary tool.

**For complex ICU patients or unexplained acid-base disorders:** Add Stewart analysis to gain additional diagnostic insight. Consider applying albumin correction to AG calculations routinely.

------------------------------------------------------------------------

## 9. Metabolic Acidosis in Chronic Kidney Disease (CKD)

### Pathophysiology: Progressive Loss of Ammoniagenesis

In healthy kidneys, **ammonia (NH3) generation** is the primary mechanism for H+ excretion and metabolic acid elimination. With progressive CKD:

**Stage 1–2 (GFR \> 60):** Minimal acid-base changes

**Stage 3–4 (GFR 15–60):** - Ammoniagenesis decreases → cannot excrete daily acid load - Initially: **NAGMA (hyperchloremic)** — kidneys retain Cl to maintain anion balance - HCO3 typically 18–22 mEq/L - Anion gap remains normal (\< 12)

**Stage 5 (GFR \< 15):** - Severe ammoniagenesis defect - Phosphate, sulfate, urate accumulate → **HAGMA develops** - Can transition from NAGMA to HAGMA - HCO3 often \< 15 mEq/L - AG may rise to 14–20

### Clinical Consequences of CKD Acidosis

**Accelerates:** - Muscle protein catabolism (BCAA loss, increased proteolysis) - Bone disease (stimulates osteoclast activity; acidosis is independent risk factor for osteoporosis) - CKD progression (acidosis accelerates nephron loss) - Vascular dysfunction and atherosclerosis acceleration - Insulin resistance

**Nutritional:** Negative nitrogen balance from increased protein breakdown

### KDIGO Targets and Management

**Goal:** Maintain serum HCO3 ≥ 22 mEq/L

**Pharmacologic options:**

#### 1. **Sodium Bicarbonate (Oral)**

- Dose: 650–1,300 mg TID–QID (1 mmol per tablet)
- Pros: Cheap, effective, raises HCO3 reliably
- Cons: Sodium load (concern in CKD); GI side effects (bloating, flatulence)
- Target: Achieve HCO3 22–24

#### 2. **Sodium Citrate**

- Dose: 1–2 mEq/kg/day divided TID
- Mechanism: Citrate is metabolized to HCO3 by liver
- Pros: Less GI upset than bicarbonate
- Cons: Still adds sodium; palatability issues

#### 3. **Veverimer (TRC101)** — Novel Agent

- Non-absorbed polymer that binds HCl in GI tract
- Mechanism: “Traps” HCl → less acid absorption → serum HCO3 rises
- Dose: 3–6 g TID with meals
- Pros: Doesn’t add sodium; well-tolerated; effective (raises HCO3 3–4 mEq/L)
- Cons: Expensive; newer agent (less long-term data)
- Recommendation: Consider in CKD Stage 3–4 if bicarbonate \< 22

#### 4. **Dietary Modification**

- Low-acid diet (reduce animal protein, high-protein foods)
- Increase fruits + vegetables (alkaline load)
- Modest impact but useful as adjunct

### Recent Evidence and Outcomes

- **KDIGO 2024 guidelines:** Recommend alkalinizing therapy for CKD patients with serum HCO3 \< 22
- **VEVERIMER-1 trial:** Veverimer increased serum HCO3 in CKD Stage 3–4; no long-term progression data yet
- **Observational data:** Correction of CKD acidosis associated with slower decline in eGFR and better nutritional status

### Key Reference

Kraut JA, Madias NE. Metabolic Acidosis of CKD: An Update. Am J Kidney Dis 2016;67(2):307-17. PMID: 26477665

------------------------------------------------------------------------

## 10. Clinical Approach Algorithm: Step-by-Step Systematic Diagnosis

### Step 1: Confirm Metabolic Acidosis

**Required findings:** - Arterial pH \< 7.35 - Serum HCO3 \< 22 mEq/L - PCO2 \< 40 mmHg (should be low from respiratory compensation)

**If pH \> 7.35:** Not acidemia. Consider metabolic alkalosis or normal acid-base with mixed picture.

### Step 2: Assess Respiratory Compensation Using Winter’s Formula

Expected PCO2 = 1.5 × \[HCO3\] + 8 ± 2

**Compare actual PCO2 to expected:**

- **Actual PCO2 within ±2 of expected:** Appropriate respiratory compensation (isolated metabolic acidosis or mixed without primary respiratory disorder)
- **Actual PCO2 HIGHER than expected:** **Primary respiratory acidosis ALSO present** (concurrent hypoventilation)
- **Actual PCO2 LOWER than expected:** **Primary respiratory alkalosis ALSO present** (excessive hyperventilation)

**Action:** If PCO2 does not match expectation, immediately consider: - Pulmonary pathology (edema, pneumonia, PE) - CNS pathology (altered mental status limiting drive to breathe, or excessive drive from acidosis, pain, anxiety) - Acid-base disorder combined with respiratory disorder

### Step 3: Calculate Anion Gap (With Albumin Correction)

AG = \[Na\] − (\[Cl\] + \[HCO3\])

**First, identify if patient is hypoalbuminemic:** - If albumin \< 4 g/dL, **correct the AG:** Adjusted AG = Measured AG + 2.5 × (4 − \[Albumin\])

**Interpretation:** - Adjusted AG \> 12: **HIGH ANION GAP** → proceed to Step 4 - Adjusted AG ≤ 12: **NORMAL ANION GAP** → proceed to Step 5

### Step 4: If High Anion Gap → Determine Cause and Calculate Delta-Delta

**HAGMA causes (GOLDMARK):** - Glycols (ethylene glycol, propylene glycol) - Oxoproline (5-oxoproline/pyroglutamic acidosis) - L-lactate - DKA / alcoholic ketoacidosis / starvation ketoacidosis - Methanol - Aspirin (salicylate) - Renal failure (uremia) - Ketoacidosis

**Diagnostic workup for HAGMA:** - **Lactate level:** Is elevated lactate present? (lactic acidosis vs. other cause) - **Glucose + beta-hydroxybutyrate/urine ketones:** Is DKA present? - **Osmolar gap + serum methanol/ethylene glycol:** Is toxin ingestion present? - **Acetaminophen history + urine pyroglutamic acid:** Is pyroglutamic acidosis present? - **Salicylate level:** Is aspirin toxicity present? - **Renal function (creatinine):** Is uremia the cause?

**Then calculate delta-delta:** *ΔAG* = AG − 12 *ΔHCO*3 = 24 − \[HCO3\] Ratio = *ΔAG*/*ΔHCO*3

- Ratio \< 1: HAGMA + NAGMA (combined)
- Ratio 1–2: Pure HAGMA
- Ratio \> 2: HAGMA + metabolic alkalosis (hidden)

**Action:** Based on cause identified and ratio, pursue targeted treatment.

### Step 5: If Normal Anion Gap → Calculate Urine Anion Gap

UAG = \[*U*_(Na) + *U*_(K)\] − \[*U*_(Cl)\]

**OR assess urine osmolar gap / direct urine ammonium (if available)**

**Interpretation:** - **UAG \< –20 (negative):** Appropriate high urine NH4+ excretion → kidneys working normally → **GI CAUSE** (diarrhea, fistula, etc.) - Action: Replace HCO3; treat underlying GI disorder

- **UAG \> 0 (positive):** Low urine NH4+ excretion → kidneys cannot respond to acidosis → **RENAL CAUSE** (RTA, Addison’s, acetazolamide, hyperkalemia)
  - Action: Identify type of RTA; check serum K+; obtain aldosterone/renin

**Additional diagnostic clues for NAGMA cause (USEDCARP):** - History of diarrhea → diarrhea (most common) - Known ureteral diversion → ureterosigmoidostomy - Recent diuretic use + low urine Cl → Addison’s disease or hypoaldosteronism - Medication history → carbonic anhydrase inhibitor (acetazolamide) or thiazide - Serum K+ is ELEVATED → Type IV RTA or Addison’s disease - Urine pH \> 5.5 despite acidemia → Type I RTA - Serum HCO3 improves with saline loading → Type II RTA (proximal)

### Step 6: Special Situations — Consider Stewart Approach

**In complex ICU patients or when traditional approach is non-diagnostic:** - Calculate corrected AG (done in Step 3 already) - Quantify **hyperchloremic effect:** Cl - 98 - Quantify **hypoalbuminemic effect:** 0.25 × (42 - albumin in g/L) - This may reveal diagnosis where traditional approach failed

### Flowchart Summary

    METABOLIC ACIDOSIS SUSPECTED
        ↓
    [Step 1] Confirm: pH < 7.35, HCO3 < 22, PCO2 < 40
        ↓
    [Step 2] Check Winter's Formula for appropriate PCO2
             PCO2 matches ±2? → Isolated MA or MA + resp alk (if lower)
             PCO2 higher than expected? → Concurrent respiratory acidosis
        ↓
    [Step 3] Calculate AG (with albumin correction if Alb < 4)
             ├─ AG > 12 → HIGH ANION GAP
             │   ↓
             │   [Step 4] HAGMA workup:
             │   - Lactate? Glucose/ketones? Osmolar gap?
             │   - Identify cause (GOLDMARK)
             │   - Calculate delta-delta ratio
             │   - Treat specific cause
             │
             └─ AG ≤ 12 → NORMAL ANION GAP
                 ↓
                 [Step 5] NAGMA workup:
                 - Calculate UAG or urine osmolar gap
                 - UAG < –20 (negative) → GI cause (diarrhea)
                 - UAG > 0 (positive) → Renal cause (RTA, Addison's)
                 - Identify specific cause (USEDCARP)
                 - Treat specific cause

------------------------------------------------------------------------

## 11. Related Resources and Wiki-Links

This comprehensive review connects to multiple other resources in your nephrology vault:

- Acid-Base Formal Review — Foundational acid-base physiology
- Acid-Base Quick Guide — Rapid reference at bedside
- SGLT2 Inhibitor Euglycemic DKA — Emerging complication of SGLT2i use
- Sodium Bicarbonate Therapy — Pharmacology and dosing of alkali
- Metabolic Alkalosis: Comprehensive Review — Counterpart disorder
- Renal Tubular Acidosis: Types I-IV Comprehensive Review — Detailed RTA pathophysiology
- Hyperkalemia — Type IV RTA and hyperkalemia relationship
- Hyperkalemia Treatment — Management of K+ in acidosis
- Acute Kidney Injury Comprehensive Review — AKI acidosis context
- AKI Staging and Classification — AKI severity assessment
- Acid-Base Student Handout — PA student learning resource

------------------------------------------------------------------------

## 12. References and Literature

1.  **Lactic Acidosis:**
    - Kraut JA, Madias NE. Lactic Acidosis. N Engl J Med. 2014;371:2309-19. PMID: 25494270
    - Kraut JA, Madias NE. Metabolic acidosis: pathophysiology, diagnosis and management. Nat Rev Nephrol. 2010;6:274-85. PMID: 20308999
2.  **Pyroglutamic Acidosis (5-Oxoproline):**
    - Humphreys BD, Forman JP, Zandi-Nejad K, et al. Acetaminophen-induced anion gap metabolic acidosis and 5-oxoprolinuria (pyroglutamic aciduria) acquired in hospital. *Am J Kidney Dis.* 2005;46(1):143-146. PMID: [15983968](https://pubmed.ncbi.nlm.nih.gov/15983968/)
    - Duewall JL et al. 5-Oxoproline (pyroglutamic) acidosis associated with chronic acetaminophen use. *Proc (Bayl Univ Med Cent).* 2010;23(1):19-20. PMID: [20157498](https://pubmed.ncbi.nlm.nih.gov/20157498/)
    - Fenves AZ, et al. 5-Oxoproline Acidosis Associated with Chronic Acetaminophen Use. Clin J Am Soc Nephrol. 2006. PMID: 17699243
3.  **Urine Anion Gap and Ammonium:**
    - Batlle DC, et al. Use of the Urinary Anion Gap in the Diagnosis of Hyperchloremic Metabolic Acidosis. N Engl J Med. 1988;318:594-9. PMID: 3344005
    - Batlle D, Ba Aqeel SH, Marquez A. The Urine Anion Gap in Context. Clin J Am Soc Nephrol. 2018;13(2):195-7. PMID: 29311217
    - Rehman MZ, Melamed M, Harris A, Shankar M. Urinary Ammonium in Clinical Medicine: Direct Measurement and the Urine Anion Gap as a Surrogate Marker During Metabolic Acidosis. Adv Kidney Dis Health. 2023;30(2):197-206. PMID: 36868734
4.  **Anion Gap Concepts:**
    - Goodkin DA, Krishna GG, Narins RG. The Role of the Anion Gap in Detecting and Managing Mixed Metabolic Acid-Base Disorders. Clin Endocrinol Metab. 1984;13(2):333-49. PMID: 6488577
    - Wrenn K. The Delta (Delta) Gap: An Approach to Mixed Acid-Base Disorders. Ann Emerg Med. 1990;19:1310-3. PMID: 2240729
5.  **Stewart (Physicochemical) Approach:**
    - Story DA, Morimatsu H, Bellomo R. Strong Ions, Weak Acids and Base Excess: A Simplified Fencl-Stewart Approach to Clinical Acid-Base Disorders. Br J Anaesth. 2004;92(1):54-60. PMID: 14665553
    - Fencl V, et al. Diagnosis of Metabolic Acid-Base Disturbances in Critically Ill Patients. Am J Respir Crit Care Med. 2000;162:2246-51.
6.  **CKD and Metabolic Acidosis:**
    - Kraut JA, Madias NE. Metabolic Acidosis of CKD: An Update. Am J Kidney Dis. 2016;67(2):307-17. PMID: 26477665
    - KDIGO Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2013.
7.  **Toxicology:**
    - References for methanol, ethylene glycol, salicylate toxicity available in specialized toxicology databases and Poisindex

------------------------------------------------------------------------

## Key Clinical Pearls Summary

CRITICAL PEARLS FOR DIAGNOSIS: 1. Always correct AG for albumin — 2.5 mEq/L for each 1 g/dL albumin below 4 2. Winter’s formula FIRST — PCO2 deviation signals respiratory component 3. Replace pyroglutamic acidosis for paraldehyde in MUDPILES mnemonic 4. Delta-delta reveals hidden disorders — ratio \< 1 or \> 2 = mixed disorder 5. UAG differentiates GI from renal NAGMA — \< –20 = GI; \> 0 = renal 6. DKA is ALWAYS triple disorder — HAGMA + NAGMA + metabolic alkalosis 7. Salicylate toxicity = acidemia + low PCO2 — unique combination 8. Stewart approach adds value in ICU — especially hypoalbuminemia, hyperchloremia RED FLAGS / HIGH-RISK SCENARIOS: - Unexplained high AG acidosis in malnourished patient on chronic acetaminophen → pyroglutamic acidosis (get plasma 5-oxoproline; give NAC immediately) - Acidosis + hyperkalemia + hyponatremia → Addison’s disease (check cortisol/ACTH) - pH \< 7.15 → Medical emergency; potential for arrhythmia, hemodynamic instability, altered mental status - Triple acid-base disorder in DKA → Treat insulin + fluids aggressively; reassess frequently - Excessive PCO2 elevation relative to HCO3 → Respiratory acidosis masking metabolic acidosis severity

------------------------------------------------------------------------

*This document is a living resource for nephrology education. Update with new evidence, clinical pearls, or additional references as vault content evolves. Last reviewed: 2026-02-28*

← Back to Electrolyte-Acid-Base Hub


---

[Website version](https://urinenephrology.org/mastery/electrolytes-advanced/metabolic-acidosis.html) · Markdown synchronized October 3, 2026.